Leucine aminopeptidase — Drug Target
All drugs that target Leucine aminopeptidase — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 3 pipeline (1)
- l-LV (dl-LV) · Epidemiological and Clinical Research Information Network · Amino acid derivative · Oncology
L-LV is a synthetic amino acid derivative that acts as a competitive inhibitor of the enzyme leucine aminopeptidase.